rs1801028, DRD2

N. diseases: 24
Disease: Neurobehavioral Manifestations ×
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Neurobehavioral Manifestations
CUI: C0525041
Disease: Neurobehavioral Manifestations
0.010 GeneticVariation BEFREE The dopamine D2 receptor (DRD2) Ser311Cys polymorphism may also play a role in determining risperidone efficacy for positive, negative and cognitive symptoms, the DRD2 Ins-A2/Del-A1 diplotype may predict better risperidone response, and the DRD3 Ser311Cys variant may affect general treatment response of several atypical agents. 15882132 2005